[Today's focus]

Kuaishou Group's adjusted net profit for the third quarter was 3.17 billion yuan, up 17.8% month-on-month

On November 21, Kuaishou announced results for the third quarter of 2023. Profitability increased dramatically. The adjusted net profit reached RMB 3.17 billion, an increase of 17.8% over the Q2 data, significantly exceeding the unanimous expectations of the Bloomberg market of 2.66 billion yuan. In the same period in 2022, the Group's adjusted net loss was RMB 670 million.

[Important matters]

Goldwind Technology (02208.HK) will invest in the construction of a zero-carbon industrial base for wind power in Beibu Gulf, with a total investment of 6 billion yuan

China Everbright Water (01857.HK) establishes a joint venture, Shaoguan Guangshui Zhenghe Environmental Technology

Futian Industrial (00420.HK): The total amount of compensation the government should pay to Jiangyin Fuhui due to land expropriation is 259 million yuan

Dalip Holdings (01921.HK) was included in the MSCI Global Small Cap Index

[Financial results]

Baidu Group - SW (09888.HK): Total revenue of 34.4 billion yuan for the third quarter

Jinshan Software (03888.HK) third quarter results: revenue exceeded 2 billion yuan, 12% year-on-year increase, core business, steady development, continued focus on AI and collaboration

Tongcheng Travel (00780.HK) released its financial report for the third quarter of 2023:225 million annual paying users, a record high

Kin Yip Industrial (00216.HK) changed profit to loss of HK$2 million in the medium term

Venture Group Holdings (02221.HK) increased mid-term revenue by approximately 6.1% to approximately HK$307 million

Ling Rui Holdings (00784.HK) Profit Warning: Expected mid-term losses of about HK$1.6 million

Professional Travel (01235.HK) expects medium term profit of approximately HK$1.6 million to HK$1.8 million

Tsui Wah Holdings (01314.HK) Profit: Expected mid-term profit of about HK$7 million

Environmental Science International (00657.HK)'s mid-term losses narrowed to around HK$3.6 million

Alpha Enterprise (00948.HK) Profit Warning: Expected medium term losses of no more than HK$25 million

[Operational data]

Huaying Construction (01582.HK) won a HK$4.2 billion construction contract

China Express (03969.HK) recently won the bid for a 3,035 billion yuan project

China Construction Industry (00830.HK) won the 510 million yuan curtain wall contract

The electricity sales volume of China Resources Electric Power (00836.HK) subsidiary power plants reached 13.63 million megawatt-hours in October, up 2.2% year-on-year

[Pharmaceutical Innovation]

Fosun Pharmaceutical (02196.HK): Drug registration applications for FCN-437c capsules combined with fluorovirusgroup to treat locally advanced or metastatic breast cancer with positive hormone receptor (HR) positive and human epidermal growth factor receptor 2 (HER2) negative for locally advanced or metastatic breast cancer with disease progression after previous endocrine treatment were accepted by the National Drug Administration

Shanghai Pharmaceutical (02607.HK): I035 obtained a clinical trial approval notice

Xiansheng Pharmaceutical (02096.HK) and Connold Biopharma enter into an exclusive licensing and cooperation agreement on IL-4Rα monoclonal antibody Rademikibart

[Acquisition and sale]

Chuangping Group Holdings (01609.HK) plans to acquire 59% of Guangzhou's shares in Xiangjing Cemetery for HK$142 million

The subsidiary of Tianjin Port Development (03382.HK) spent 16.988 million yuan to purchase 1 portal crane

Shengneng Group (02459.HK): Controlling shareholder Otautahi Capital Inc transferred 20 million shares of the company to a group of individuals free of charge

China Financial Holdings (00875.HK) subsidiary transfers 49% of Guangdong's shares in Yuyu Import and Export to Guangzhou Conghua Food Development Group

120,000 shares of the company held by Lai Tzi-ming, chairman of the board of directors of Abel Technology (02708.HK), were forcibly sold

[Equity Incentives]

CIMC Enrico (03899.HK) granted a total of 39.5 million options to 208 eligible persons

Pharmaceutical Biology (02269.HK) grants 3,037,200 restricted shares and 7.8894 million restricted shares in the Global Partner Program

[Repurchase Cancellation]

Tencent Holdings (00700.HK) spent HK$400 million to repurchase 1.22 million shares on November 21

HSBC Holdings (00005.HK) spent HK$197 million to repurchase 3.274 million shares on November 20

AIA (01299.HK) spent HK$135 million to repurchase 1.84 million shares on November 21

Yum China (09987.HK) spent $11.5 million to repurchase 249,000 shares on November 20

China Petroleum & Chemical Co., Ltd. (00386.HK) spent HK$39.95 million to repurchase 9.522 million shares on November 21

EasyPoint Cloud (02416.HK) plans to use up to HK$20 million to implement share repurchases

COSCO Marine Control (01919.HK) spent HK$14.4223 million to repurchase 1,965 million shares on November 21

Conch Cement (00914.HK) spent 13.326,500 yuan to repurchase 560,000 A-shares on November 21

ESR (01821.HK) spent HK$8.87 million to repurchase 880,000 shares on November 21

Jiumaojiu (09922.HK) spent HK$5.05 million to repurchase 581,000 shares on November 21

Shanghai Petrochemical Co., Ltd. (00338.HK) spent HK$4.275,900 to repurchase 3.738 million shares on November 21

Guichuang Tongqiao-B (02190.HK) spent HK$2.05,000 to repurchase 180,000 shares on November 21

China Xuyang Group (01907.HK) spent HK$1,976,000 to repurchase 600,000 shares on November 21